HEART FAILURE REVIEWS

Scope & Guideline

Pioneering Discoveries in Heart Failure Therapies

Introduction

Explore the comprehensive scope of HEART FAILURE REVIEWS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore HEART FAILURE REVIEWS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1382-4147
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1996 to 2024
AbbreviationHEART FAIL REV / Heart Fail. Rev.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal "Heart Failure Reviews" aims to provide comprehensive insights into various aspects of heart failure, focusing on advancements in treatment, diagnosis, and management strategies. It encompasses a wide range of topics, including clinical studies, systematic reviews, and innovative therapies, making significant contributions to the field of cardiology.
  1. Clinical Management of Heart Failure:
    The journal emphasizes the importance of clinical management strategies for heart failure, including pharmacological treatments, lifestyle interventions, and the use of advanced therapies such as device management and surgical options.
  2. Innovative Therapeutic Approaches:
    Research published in the journal often explores novel therapeutic approaches, such as the use of SGLT2 inhibitors, GLP-1 receptor agonists, and other emerging drugs, highlighting their efficacy and mechanisms in heart failure management.
  3. Diagnosis and Prognosis:
    The journal focuses on advancements in diagnostic techniques, including echocardiography, cardiac MRI, and biomarkers, as well as prognostic tools that aid in assessing heart failure severity and outcomes.
  4. Pathophysiology and Mechanisms:
    A significant portion of the articles delve into the underlying mechanisms and pathophysiology of heart failure, including molecular, genetic, and inflammatory aspects that contribute to disease progression.
  5. Comorbidities and Multidisciplinary Care:
    The journal promotes the understanding of comorbid conditions associated with heart failure, advocating for a multidisciplinary approach to patient care that addresses both cardiac and non-cardiac issues.
The journal has shown an evolving focus on emerging trends and novel therapeutic approaches in heart failure management. Recent publications reflect a growing interest in integrating technology, personalized medicine, and innovative pharmacotherapies.
  1. Digital Health and Telemonitoring:
    The integration of digital health technologies and telemonitoring for heart failure management is increasingly highlighted, showcasing the potential for improving patient outcomes through remote monitoring and engagement.
  2. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF is gaining traction, with a focus on its unique challenges, therapeutic options, and the development of specific management guidelines, reflecting a better understanding of this complex condition.
  3. Personalized and Precision Medicine:
    There is a growing trend towards personalized medicine in heart failure treatment, with an emphasis on tailoring therapies based on genetic, molecular, and phenotypic characteristics of patients.
  4. Innovative Biomarkers and Diagnostic Tools:
    The exploration of novel biomarkers and advanced diagnostic tools, such as cardiac imaging techniques and machine learning algorithms, is becoming more prevalent, enhancing the ability to stratify risk and personalize treatment.
  5. Impact of Lifestyle Modifications:
    Recent publications increasingly emphasize the significance of lifestyle modifications, including dietary and exercise interventions, as integral components of heart failure management.

Declining or Waning

While the journal continues to thrive in many areas, certain themes appear to be losing prominence in recent publications. This may reflect shifts in research focus or advancements in treatment options that have rendered some topics less critical or outdated.
  1. Traditional Pharmacological Approaches:
    There seems to be a decreasing emphasis on traditional pharmacological treatments such as ACE inhibitors and beta-blockers, as newer therapies like SGLT2 inhibitors gain prominence in heart failure management.
  2. Isolated Studies on Specific Comorbidities:
    Research focusing solely on specific comorbidities without integrating them into a broader heart failure management context is becoming less frequent, indicating a shift towards more holistic approaches.
  3. Generalized Risk Factors:
    Articles that discuss generalized risk factors for heart failure without specific context or innovative approaches are appearing less often, as the field moves towards more targeted and individualized treatment strategies.

Similar Journals

Netherlands Heart Journal

Leading the Way in Cardiovascular Research and Practice
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

CARDIOLOGY CLINICS

Elevating the discourse on cardiovascular health worldwide.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8651Frequency: 4 issues/year

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.

Hellenic Journal of Cardiology

Empowering Heart Health Through Innovative Research
Publisher: ELSEVIERISSN: 1109-9666Frequency: 6 issues/year

The Hellenic Journal of Cardiology, a peer-reviewed open-access publication under the esteemed ELSEVIER banner, proudly represents the forefront of research in the field of Cardiology and Cardiovascular Medicine. Established in 1993 and actively publishing since then, this journal has carved a niche in disseminating high-quality research and clinical insights relevant to cardiovascular health in Greece and beyond. With an impressive Q2 ranking in both Cardiology and Cardiovascular Medicine categories as of 2023, the journal holds a commendable position at Rank #126/387 in Scopus, indicative of its critical role in advancing scientific knowledge and practice. The Hellenic Journal of Cardiology transitioned to open access in 2016, ensuring that ground-breaking research is freely accessible, fostering a global dialogue among researchers, clinicians, and students alike. Its publication frequency spans significant years, providing a continuous flow of innovative findings while addressing pressing cardiovascular issues. As the journal builds on its legacy, it aspires to enrich the academic community's understanding of cardiovascular medicine, making it an invaluable resource for anyone invested in heart health.

Journal of Cardiovascular Medicine

Shaping the Future of Cardiovascular Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1558-2027Frequency: 12 issues/year

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

CURRENT OPINION IN CARDIOLOGY

Navigating the latest trends in cardiovascular medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0268-4705Frequency: 6 issues/year

CURRENT OPINION IN CARDIOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed journal in the field of cardiology that has been serving the academic community since 1988. With a robust focus on the latest developments and emerging trends in cardiovascular medicine, this journal aims to bridge the gap between clinical practice and research, offering critical insights and expert commentary. The journal is recognized in the medical community, achieving a 2023 Scopus rank of #148 out of 387 in its category, placing it in the 61st percentile. Although it operates under a subscription-based model, CURRENT OPINION IN CARDIOLOGY remains an essential resource for researchers, practitioners, and students seeking cutting-edge knowledge and advancements in cardiology. As a Q2 journal in the field, it continues to foster dialogue and provide a platform for disseminating impactful cardiovascular research, ultimately contributing to improved patient outcomes and informed clinical decisions.

Arquivos Brasileiros de Cardiologia

Connecting the global cardiology community through innovative research.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

Journal fur Kardiologie

Advancing Cardiovascular Knowledge, One Study at a Time.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1024-0098Frequency: 12 issues/year

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

CARDIOVASCULAR RESEARCH

Unveiling the future of heart health research.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

International Journal of Cardiology

Elevating Standards in Cardiology Research and Practice
Publisher: ELSEVIER IRELAND LTDISSN: 0167-5273Frequency: 24 issues/year

The International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.

BASIC RESEARCH IN CARDIOLOGY

Leading the way in high-quality cardiovascular research.
Publisher: SPRINGER HEIDELBERGISSN: 0300-8428Frequency: 6 issues/year

BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.